Neurochemical effects of CGRP.
Drumheller
A
A
Department of Psychiatry, Faculty of Medicine, University of Sherbrooke, Quebec, Canada.
Menard
D
D
Fournier
A
A
Jolicoeur
F B
FB
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D015740:Calcitonin Gene-Related Peptide / Q000008:administration & dosage / Q000494:pharmacology*; D002552:Cerebral Ventricles / Q000187:drug effects / Q000502:physiology*; D004298:Dopamine / Q000378:metabolism*; D006719:Homovanillic Acid / Q000378:metabolism; D007276:Injections, Intraventricular; D008297:Male; D009928:Organ Specificity; D051381:Rats; D011919:Rats, Inbred Strains
D015102:3,4-Dihydroxyphenylacetic Acid; D015740:Calcitonin Gene-Related Peptide; D004298:Dopamine; D006719:Homovanillic Acid